Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
QIAGEN N.V. to be acquired by Thermo Fisher Scientific
Diploid was acquired by Invitae
TeraRecon was acquired by SymphonyAI
Marker Gene Technologies was acquired by Abcam
Tempus Labs received $100 Million in Series G Financing